Cell Robotics Receives First Order from China for Sixty Personal Lasettes.

Business Editors & Health/Medical Writers

ALBUQUERQUE, N.M.--(BW HealthWire)--Aug. 23, 2000

Cell Robotics International Inc. (OTC:CRII), a manufacturer and marketer of medical and scientific laser devices, today announced that it has received its first order of 60 Personal Lasettes(R) from Chinese distributor C.A. Continentals Inc. (CAC).

The award-winning Personal Lasette is a miniature laser finger perforator, slightly larger than a cell phone, that allows diabetics to test blood glucose levels with minimal pain, no lingering soreness and less residual bleeding, and eliminates the steel lancet for needle phobics.

C.A. Continentals has received approval from the Chinese regulatory authorities to distribute the Lasette in China. The company distributes medical products with partnership companies and has more than 60 offices located throughout China. This network consists of both state-owned and private distributors, covering every province in China.

With headquarters in Beijing, China, CAC develops and manages its U.S. medical products through a subsidiary office in Orlando, Fla. CAC and its partnership companies had sales of $250 million in 1997, making CAC one of the largest medical distribution companies in China. CAC has already prepared a newsletter describing the Lasette and will exhibit it at an upcoming tradeshow in the Kuam Dong province.

Dr. Ronald K. Lohrding, president of Cell Robotics, stated: "We are extremely pleased with C.A. Continentals Inc. The company undertook a thorough market study, and given the eagerness of its staff to launch the Lasette and consistent track record of success, we are confident in their abilities to aggressively sell our Lasette in China."

Lohrding continued: "Travis Lee, vice president of sales and marketing, and Irene Ho, international sales coordinator, left yesterday to meet with several organizations in Asia, including distributors in Japan, Taiwan, Korea and CAC in China. While in the region, they will also attend the Hospi Medica (Asia). This convention in Singapore runs August 29-31 and is expected to draw 80,000 people and thousands of medical distributors."

Diabetes, a chronic disease, is the most costly of all diseases in the United States and is the sixth leading cause of death worldwide. The International Diabetes Institute provides the following numbers of people with diabetes by region: 16.9 million in North America, 23.7 million in Europe, 51.2 million in Asia and 12.6 million in Latin America.

Detailed information about purchasing the Lasette and media-quality photographs can be found at www.cellrobotics.com or by calling 800/846-0590. Interested distributors should submit a form at http://www.cellrobotics.com/DIS_Form.html.

As a cautionary note to investors, certain matters discussed in this news release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; the company's ability to execute its service and product sales plans; and the risks described from time to time in the company's Securities and Exchange Commission filings.